Medical research

A two-day summit opened in Belgrade on Monday to mark the 60th anniversary of the first conference of the Non-Aligned Movement, established to create a third global bloc in a world polarised by the East-West Cold War.

Delegations from more than 105 countries and nine international organizations are taking part in the gathering, hosted by Serbia.

This winter will be a difficult period in the fight against COVID-19 due to increased mobility and complacent behavior shown, particularly by young people toward vaccination and anti-virus rules, an expert has warned.

Turkey's health minister has urged young people to get their vaccines against COVID-19, noting that the new coronavirus cases are mostly seen among this age group.

Recently, Fahrettin Koca said that more than half of the active cases in the country were found among people under the age of 30.

Iceland on Oct. 8 suspended the Moderna anti-Covid vaccine, citing the slight increased risks of cardiac inflammation, going further than its Nordic neighbors which simply limited use of the jabs.

Pfizer Inc and BioNTech SE have asked U.S. regulators to authorize emergency use of their COVID-19 vaccine for children ages 5 to 11, a group for whom no shot is currently allowed, Pfizer said on Oct. 7.

Fully vaccinated travelers from dozens of more countries, including Turkey, will not be required to self-isolate in the U.K. starting next week, the British government has announced.

EU legislation does not foresee checking the validity of certificates issued to fully vaccinated against COVID-19. This was stated today by a spokesman for the European Commission on the occasion of the decision of several EU countries to switch to an additional dose of vaccine.

A total of 791,141 people have been fully vaccinated in the Republic of North Macedonia by October 4th, and 425 have received a third booster dose, the country's health ministry announced on Tuesday, MIA reported.

Infectious disease experts emphasized that this vaccine and others for COVID-19 nonetheless remain highly protective against severe disease and death

The pharmaceutical company AstraZeneca announced it was seeking authorization for usage in US of a medicine related to the treatment from coronavirus infection. The medicine is aimed to prevent Covid-19 for people who respond poorly or do not respond at all to vaccines because of a weakened immune system, Reuters reported.